Yield10 Bioscience (NASDAQ:YTEN) Shares Cross Above 200-Day Moving Average of $0.27

Yield10 Bioscience, Inc. (NASDAQ:YTENGet Free Report)’s share price crossed above its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of $0.27 and traded as high as $0.36. Yield10 Bioscience shares last traded at $0.33, with a volume of 1,220,724 shares changing hands.

Analyst Upgrades and Downgrades

Separately, Lake Street Capital lowered Yield10 Bioscience from a “buy” rating to a “hold” rating in a research report on Thursday, February 8th.

View Our Latest Report on Yield10 Bioscience

Yield10 Bioscience Trading Down 11.2 %

The company has a fifty day moving average of $0.29 and a two-hundred day moving average of $0.27. The stock has a market capitalization of $5.13 million, a price-to-earnings ratio of -0.16 and a beta of 1.58.

Institutional Trading of Yield10 Bioscience

An institutional investor recently bought a new position in Yield10 Bioscience stock. Jane Street Group LLC purchased a new position in shares of Yield10 Bioscience, Inc. (NASDAQ:YTENFree Report) in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 13,658 shares of the specialty chemicals company’s stock, valued at approximately $72,000. Jane Street Group LLC owned about 0.28% of Yield10 Bioscience at the end of the most recent reporting period. 4.91% of the stock is currently owned by hedge funds and other institutional investors.

About Yield10 Bioscience

(Get Free Report)

Yield10 Bioscience, Inc operates as agricultural bioscience company in the United States. The company primarily focus on production of low carbon products through processing Camelina seeds. Its products include Camelina oil for low carbon biofuel feedstock; Omega-3 oils for nutrition; and PHA bioplastics for biodegradable zero waste packaging solutions.

See Also

Receive News & Ratings for Yield10 Bioscience Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Yield10 Bioscience and related companies with MarketBeat.com's FREE daily email newsletter.